Evaluation of biomarkers and surrogate endpoints in chronic disease /

"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in ord...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease
Otros Autores: Micheel, Christine, Ball, John, 1944-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2010.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Biochemical markers > Evaluation.
Chronic diseases.
Biochemical markers.
Evidence-based medicine.
Biomarkers
Chronic Disease
Evidence-Based Practice
Marqueurs biologiques > Évaluation.
Maladies chroniques.
Marqueurs biologiques.
Médecine factuelle.
TECHNOLOGY & ENGINEERING > Biomedical.
MEDICAL > Family & General Practice.
MEDICAL > Allied Health Services > Medical Technology.
MEDICAL > Biotechnology.
MEDICAL > Lasers in Medicine.
Evidence-based medicine
Biochemical markers
Biochemical markers > Evaluation
Chronic diseases
Acceso en línea:Texto completo

Internet

Texto completo

Items no disponibles

Detalle de Existencias desde

Ejemplares similares